BVXP: Bioventix PLC - Summary | Jitta

Bioventix PLC

LON:BVXP

Price
£16.75
Loss Chance
49.2%
4.62JITTA SCORE
122.74%Over Jitta Line
Jitta Ranking
525 / 884
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (36)
Recent Business Performance (44)
Financial Strength (64)
Return to Shareholders (69)
Competitive Advantage (57)
Jitta Signs
Operating MarginExpansion
Debt LevelLow Long Term Debt
Return on EquityConsistently High
CapExVery Low
Revenue and EarningEarning decline from 2022-2025
Recent Business PerformanceEarning decline 7.93% in the last year
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
4.62
122.74%
1.95
101.42%
3.14
125.88%
Biotechnology
0.34
100.00%
2.08
100.00%
1.85
100.00%
COMPANY DESCRIPTION
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.